Peers of Palvella Therapeutics Inc (PVLA)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
4481.09x
As of Mar 28, 2025
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Mar 28, 2025 | 4481.09x |
| Mar 27, 2025 | 4410.53x |
| Mar 26, 2025 | 4445.81x |
| Mar 25, 2025 | 4308.83x |
| Mar 24, 2025 | 4433.36x |
| Mar 21, 2025 | 4489.40x |
| Mar 20, 2025 | 4342.04x |
| Mar 19, 2025 | 4379.40x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison